Daiwa Securities Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.8M Buy
1,029,019
+58,079
+6% +$1.52M 0.05% 212
2026
Q1
$27.3M Buy
970,940
+51,769
+6% +$1.38M 0.08% 141
2025
Q4
$22.9M Buy
919,171
+28,895
+3% +$729K 0.07% 166
2025
Q3
$22.7M Buy
890,276
+39,782
+5% +$982K 0.08% 162
2025
Q2
$20.6M Buy
850,494
+40,505
+5% +$945K 0.08% 170
2025
Q1
$20.5M Buy
809,989
+65,853
+9% +$1.72M 0.09% 153
2024
Q4
$19.7M Sell
744,136
-60,386
-8% -$1.64M 0.09% 139
2024
Q3
$23.3M Buy
804,522
+165,611
+26% +$4.83M 0.11% 119
2024
Q2
$17.9M Buy
638,911
+55,442
+10% +$1.53M 0.1% 127
2024
Q1
$16.2M Buy
583,469
+73,183
+14% +$2.03M 0.09% 129
2023
Q4
$14.7M Buy
510,286
+23,986
+5% +$725K 0.09% 127
2023
Q3
$16.1M Buy
486,300
+31,201
+7% +$1.1M 0.11% 110
2023
Q2
$16.7M Buy
455,099
+8,445
+2% +$329K 0.11% 101
2023
Q1
$18.2M Buy
446,654
+26,964
+6% +$1.16M 0.13% 91
2022
Q4
$21.5M Buy
419,690
+30,344
+8% +$1.45M 0.17% 79
2022
Q3
$17M Buy
389,346
+13,185
+4% +$641K 0.14% 83
2022
Q2
$19.7M Buy
376,161
+7,654
+2% +$390K 0.15% 76
2022
Q1
$19.1M Sell
368,507
-8,672
-2% -$450K 0.12% 91
2021
Q4
$22.3M Buy
377,179
+2,893
+0.8% +$143K 0.13% 85
2021
Q3
$16.4M Buy
374,286
+20,672
+6% +$916K 0.11% 99
2021
Q2
$13.8M Buy
353,614
+13,301
+4% +$517K 0.09% 108
2021
Q1
$12.3M Buy
340,313
+4,332
+1% +$154K 0.09% 111
2020
Q4
$12.4M Sell
335,981
-11,427
-3% -$419K 0.1% 108
2020
Q3
$12.1M Sell
347,408
-8,441
-2% -$296K 0.11% 92
2020
Q2
$385K Hold
355,849
0.01% 625
2020
Q1
$11M Buy
355,849
+27,711
+8% +$944K 0.11% 88
2019
Q4
$12.2M Buy
328,138
+3,655
+1% +$130K 0.1% 93
2019
Q3
$11.1M Buy
324,483
+15,380
+5% +$559K 0.09% 99
2019
Q2
$12.7M Sell
309,103
-2,881
-0.9% -$114K 0.11% 89
2019
Q1
$12.6M Sell
311,984
-15,493
-5% -$620K 0.11% 88
2018
Q4
$13.6M Buy
327,477
+11,984
+4% +$497K 0.13% 79
2018
Q3
$13.2M Buy
315,493
+12,733
+4% +$490K 0.11% 82
2018
Q2
$10.4M Sell
302,760
-25,881
-8% -$884K 0.08% 122
2018
Q1
$12M Sell
328,641
-14,188
-4% -$488K 0.1% 104
2017
Q4
$11.8M Buy
342,829
+21,320
+7% +$727K 0.08% 106
2017
Q3
$10.9M Sell
321,509
-3,767
-1% -$121K 0.07% 124
2017
Q2
$10.4M Sell
325,276
-8,980
-3% -$283K 0.07% 121
2017
Q1
$10.8M Buy
334,256
+2,761
+0.8% +$87.1K 0.07% 122
2016
Q4
$10.2M Sell
331,495
-545,286
-62% -$16.6M 0.07% 94
2016
Q3
$28.2M Buy
876,781
+25,021
+3% +$837K 0.17% 55
2016
Q2
$28.5M Buy
851,760
+74,729
+10% +$2.39M 0.17% 53
2016
Q1
$21.9M Buy
777,031
+175,386
+29% +$5.01M 0.14% 60
2015
Q4
$18.4M Sell
601,645
-41,317
-6% -$1.3M 0.12% 65
2015
Q3
$19.2M Sell
642,962
-57,970
-8% -$1.86M 0.14% 64
2015
Q2
$22.3M Buy
700,932
+541,141
+339% +$17.6M 0.16% 65
2015
Q1
$5.28M Sell
159,791
-4,743
-3% -$151K 0.04% 170
2014
Q4
$4.86M Sell
164,534
-20,658
-11% -$592K 0.03% 162
2014
Q3
$5.2M Sell
185,192
-11,383
-6% -$319K 0.04% 148
2014
Q2
$5.54M Sell
196,575
-777,114
-80% -$22.2M 0.04% 144
2014
Q1
$29.7M Buy
973,689
+418,543
+75% +$12.5M 0.23% 46
2013
Q4
$16.1M Sell
555,146
-106,559
-16% -$3.1M 0.14% 66
2013
Q3
$18M Sell
661,705
-57,356
-8% -$1.56M 0.14% 62
2013
Q2
$19.1M Buy
+719,061
New +$19.9M 0.14% 59

Other funds holding PFE

Daiwa Securities Group's PFE Position: Q2 2026 in Review

Daiwa Securities Group increased its Pfizer (PFE) stake by 6% in Q2 2026, buying an estimated $1.52M and bringing the position to 1,029,019 shares worth $24.8M. The position accounts for 0.05% of the portfolio, ranked #212.

Daiwa Securities Group first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $29.7M in Q1 2014. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Daiwa Securities Group held 1,029,019 shares of Pfizer worth $24.8M as of Q2 2026.
  • Daiwa Securities Group bought 58,079 Pfizer shares in Q2 2026, an estimated $1.52M.
  • Pfizer made up 0.05% of Daiwa Securities Group's portfolio in Q2 2026, its #212 holding.
  • Daiwa Securities Group first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Daiwa Securities Group's Pfizer position peaked at $29.7M in Q1 2014.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Daiwa Securities Group's 13F filing for Q2 2026, filed 31 Jul 2026.